First Acceptance (FAC) Tough quarter for auto insurer. Drops to $4.94 from 52-week high of $11.77.
Bowater Incorporated (BOW) Loses abitration with Weyerhause. Down to 14.60 from 52-week high of $29.96. Business combination with Abitibi approved.
Abitibi-Price (ABY) Shareholders seem unhappy with marriage with Bowater. Down to $1.72 from 52-week high of $3.51.
Harley-Davidson (HOG) Bad numbers continue to dog the hog. Down to $46.35 from 52-week high of $75.87.
ACE*COMM (ACEC) Delisted from Nasdaq. Falls to $.42 from 52-week high of $1.92.
Neurobiological Technologies (NTII) Loss in last quarter. Drops to $.57 from 52-week high of $3.22.
Encysive Pharmaceuticals (ENCY) Biopharma drops to $1.46 from 52-week high of $7.10.
Douglas A. McIntyre
“The Next NVIDIA” Could Change Your Life
NVIDIA has returned 250-fold in the past 10 years as artificial intelligence took off.
But if you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over.
The 24/7 Wall Street Analyst who first called NVIDIA’s AI-fueled rise in 2009 just published a brand-new research report named “The Next NVIDIA.”
The report outlines key breakthroughs in AI and the stocks ready to dominate the next wave of growth. The report is absolutely free. Simply enter your email below
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.
